Chinese Traditional and Herbal Drugs
|
2025, 56(17): 6389-6403
Ferroptosis-driven targeted therapy of artemisinin derivatives across multiple diseases
Full
DAI Guonian1,2, SUN Kairui1,2, ZHOU Yaxin1, LI Bing1, PENG Xiaoting3, LIU Junzheng3, ZHOU Xuzheng1, ZHANG Jiyu1,2
Affiliations
1 Lanzhou Institute of Animal Husbandry and Veterinary Medicine, Chinese Academy of Agricultural Sciences, Lanzhou 730050, China; 2 Gansu Agricultural University, Lanzhou 730070, China; 3 Lanzhou Biopharmaceutical Factory of Zhongmu Industry Co., Ltd., Lanzhou 730046, China
About Author:
中国农业科学院创新工程 (CAAS-ASTIP-2014-LIHPS); 国家肉牛牦牛产业技术体系 (CARS-37)
doi: 10.7501/j.issn.0253-2670.2025.17.027
Outline
Ferroptosis is an iron-dependent form of cell death characterized by the accumulation of lipid peroxides, which is closely associated with tumors, neurodegenerative diseases, and metabolic disorders. Artemisinin derivatives induce ferroptosis through multi-target regulation: their active groups chelate free iron ions to generate reactive oxygen species via the Fenton reaction; selectively inhibit glutathione peroxidase 4 (GPX4) activity; and reprogram lipid metabolism mediated by acyl-CoA synthetase long-chain family member 4. Structure-activity relationship studies indicate that chemical modifications at the C-10 position significantly enhance ferroptosis-inducing efficacy. Dihydroartemisinin suppresses hepatocellular carcinoma growth by activating p53/GPX4 axis. Artesunate treats esophageal squamous carcinoma by targeting the cystine/glutamate reverse transport system (System Xc-)/glutathione pathway. Artemether alleviates liver fibrosis by modulating the iron regulatory protein 2-mediated iron metabolism network. Mechanistically, the unique “hydrogen peroxide bridge” in artemisinins is crucial for iron-dependent reactive oxygen species generation. Additionally, artemisinins modulate heme oxygenase-1-mediated iron release and the dynamic balance of the nuclear factor E2-related factor 2/Kelch-like ECH-associated protein 1 antioxidant pathway, broadening application scenarios of ferroptosis regulation in diseases like atherosclerosis. This research provides novel lead compounds for major disease interventions and establishes a paradigm for interdisciplinary studies between natural active components and modern cell death mechanisms, offering significant scientific value for advancing targeted drug development and the modernization of traditional Chinese medicine.
ferroptosis
/
artemisinin derivatives
/
glutathione peroxidase 4
/
Fenton reaction
/
liver cancer
/
modernization of traditional Chinese medicine
/
dihydroartemisinin
/
artesunate
/
artemether
代国年, 孙凯瑞, 周雅馨, 李冰, 彭晓婷, 刘君正, 周绪正, 张继瑜.
基于铁死亡的青蒿素衍生物多病靶向治疗研究进展.
中草药,
2025
, 56
(17)
: 6389
-6403
.
DOI: 10.7501/j.issn.0253-2670.2025.17.027
DAI Guonian, SUN Kairui, ZHOU Yaxin, LI Bing, PENG Xiaoting, LIU Junzheng, ZHOU Xuzheng, ZHANG Jiyu.
Ferroptosis-driven targeted therapy of artemisinin derivatives across multiple diseases[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(17)
: 6389
-6403
.
DOI: 10.7501/j.issn.0253-2670.2025.17.027
Year 2025 volume 56 Issue 17
45
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.17.027
- Receive Date:2025-04-27
- Online Date:2026-11-12